findmyKOL
Clinical trialNCT01673672TerminatedPhase 2Interventional

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

SponsorCytos Biotechnology AGEnrollment365Moderate to Severe Allergic Asthma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Czechia
  • Cytos Investigator Sites

    Kyjov, Czechia

  • Cytos Investigator Sites

    Olomouc, Praha, Tabor, Ostrava, Hradec Kralove, Plzen, Brno, Czechia

Germany
  • Cytos Investigator Sites

    Bad Woerishofen, Leipzig, Magdeburg, Germany

  • Cytos Investigator Sites

    Frankfurt aM, Delitzsch, Bonn, Berlin, Ruedersdorf, Germany

Hungary
  • Cytos Investigator Sites

    Szazhalombatta, Komaron, Hungary

  • Cytos Investigator Sites

    Tatabanya, Szombathely, Csorna, Budapest, Balassagyarmat, Hungary

Israel
  • Cytos Investigator Sites

    Haifa, Zerifin, Israel

  • Cytos Investigator Sites

    Rehovot, Petach Tikva, Ramat Gan, Jerusalem, Ashkelon, Afula, Israel

Poland
  • Cytos Investigator Sites

    Slupsk, Lodz, Tarnow, Pila, Poznan, Wroclaw, Poland

Russia
  • Cytos Investigator Sites

    Tomsk,St.Petersburg,Yaroslavl,Novosibirsk,Smolensk,Barnaul, Russia

  • Cytos Investigator Sites

    Yekaterinburg, Russia

Ukraine
  • Cytos Investigator Sites

    Donetsk, Kharkiv, Kiew, Chernivtsi, Zaporizhzhya, Mykolayiv, Ukraine

  • Cytos Investigator Sites

    Vinnytsya, Ivano-Frankivsk, Ukraine

United States
  • Cytos Investigator Sites

    Los Angeles, Huntington Beach, San Jose, California, United States

  • Cytos Investigator Sites

    Walnut Creek, San Diego, Riverside, Fountain Valley, California, United States

  • Cytos Investigator Sites

    Colorado Springs, Denver, Colorado, United States

  • Cytos Investigator Sites

    Waterbury, Connecticut, United States

  • Cytos Investigator Sites

    Miami, Tallahassee, Florida, United States

  • Cytos Investigator Sites

    Albany, Georgia, United States

  • Cytos Investigator Sites

    South Bend, Indiana, United States

  • Cytos Investigator Sites

    Metairie, Louisiana, United States

  • Cytos Investigator Sites

    Bangor, Maine, United States

  • Cytos Investigator Sites

    Bethesda, Maryland, United States

  • Cytos Investigator Sites

    North Dartmouth, Massachusetts, United States

  • Cytos Investigator Sites

    St Louis, Missouri, United States

  • Cytos Investigator Sites

    Ohmaha, Bellevue, Nebraska, United States

  • Cytos Investigator Sites

    Rochester, New York, United States

  • Cytos Investigator Sites

    Cincinnati, Ohio, United States

  • Cytos Investigator Sites

    Oklahoma City, Oklahoma, United States

  • Cytos Investigator Sites

    Eugene, Medford, Oregon, United States

  • Cytos Investigator Sites

    Providence, Warwick, Rhode Island, United States

  • Cytos Investigator Sites

    Spartanburg, Summerville, South Carolina, United States

  • Cytos Investigator Sites

    San Antonio, Texas, United States

  • Cytos Investigator Sites

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2012
Primary completion
31 May 2014
Completion
31 May 2014
Last update posted
14 May 2014
Registered enrollment
365
Registry id
NCT01673672

Cross-registrations

EU-CTR / CTIS (EudraCT)2012-003070-39

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.